» Articles » PMID: 18937353

Genetic and Biochemical Determinants of Serum Concentrations of Monocyte Chemoattractant Protein-1, a Potential Neural Tube Defect Risk Factor

Abstract

Background: Women with the AA genotype at the (-2518)A>G promoter polymorphism of CCL-2, which encodes the potent pro-inflammatory chemokine monocyte chemoattractant protein 1 (MCP-1), may be at increased risk for having offspring affected by spina bifida. As the A allele at this locus has been associated with decreased transcription of MCP-1 mRNA relative to the G allele, the observed genetic association suggests that the risk of spina bifida may be increased in the offspring of women with low MCP-1 levels. The present study was undertaken to identify potential determinants of MCP-1 levels in women of reproductive age.

Methods: A small cohort of Caucasian and African-American women of reproductive age was recruited to participate in an exploratory investigation of the determinants of several disease-related, biochemical phenotypes, including MCP-1. Subjects completed a brief questionnaire and provided a fasting blood sample for biochemical and genetic studies. Potential biochemical, genetic, and lifestyle factors were assessed for their association with MCP-1 levels using linear regression analyses.

Results: In this cohort, MCP-1 levels were significantly higher in Caucasians as compared to African-Americans. Further, among women of both races, there was evidence that MCP-1 levels were associated with smoking status, MTHFR 677C>T genotype, and red blood cell tetrahydrofolate levels.

Conclusions: The results of these analyses indicate that, if maternal CCL-2 genotype is related to the risk of spina bifida, this relationship is likely to be more complex than initially hypothesized, perhaps depending upon folate intake, MTHFR 677C>T genotype, the distribution of folate derivatives, and immune/inflammatory activity.

Citing Articles

Inflammatory proteins are associated with mortality in a middle-aged diverse cohort.

Noren Hooten N, Mode N, Allotey S, Ezike N, Zonderman A, Evans M Clin Transl Med. 2023; 13(9):e1412.

PMID: 37743657 PMC: 10518496. DOI: 10.1002/ctm2.1412.


Identification of the Key Regulators of Spina Bifida Through Graph-Theoretical Approach.

Tamkeen N, Alomar S, Alqahtani S, Al-Jurayyan A, Farooqui A, Tazyeen S Front Genet. 2021; 12:597983.

PMID: 33889172 PMC: 8056047. DOI: 10.3389/fgene.2021.597983.


Distinct DNA methylation profiles in subtypes of orofacial cleft.

Sharp G, Ho K, Davies A, Stergiakouli E, Humphries K, McArdle W Clin Epigenetics. 2017; 9:63.

PMID: 28603561 PMC: 5465456. DOI: 10.1186/s13148-017-0362-2.


Neither folic acid supplementation nor pregnancy affects the distribution of folate forms in the red blood cells of women.

Hartman B, Fazili Z, Pfeiffer C, OConnor D J Nutr. 2014; 144(9):1364-9.

PMID: 24991041 PMC: 4811356. DOI: 10.3945/jn.113.189233.


The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D).

Raison C, Miller A Mol Psychiatry. 2012; 18(1):15-37.

PMID: 22290120 PMC: 3532038. DOI: 10.1038/mp.2012.2.


References
1.
Barber R, Shalat S, Hendricks K, Joggerst B, Larsen R, Suarez L . Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas hispanic population. Mol Genet Metab. 2000; 70(1):45-52. DOI: 10.1006/mgme.2000.2991. View

2.
Lu Z, Jensen L, Huang Y, Kealey C, Blair I, Whitehead A . The up-regulation of monocyte chemoattractant protein-1 (MCP-1) in Ea.hy 926 endothelial cells under long-term low folate stress is mediated by the p38 MAPK pathway. Atherosclerosis. 2009; 205(1):48-54. PMC: 2715998. DOI: 10.1016/j.atherosclerosis.2008.12.008. View

3.
Schoenwolf G, Smith J . Mechanisms of neurulation: traditional viewpoint and recent advances. Development. 1990; 109(2):243-70. DOI: 10.1242/dev.109.2.243. View

4.
. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet. 1991; 338(8760):131-7. View

5.
Czeizel A, Dudas I . Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992; 327(26):1832-5. DOI: 10.1056/NEJM199212243272602. View